GSK329   Click here for help

GtoPdb Ligand ID: 11806

Synonyms: compound 47 [PMID: 34699203] | GSK-329
PDB Ligand
Compound class: Synthetic organic
Comment: GSK329 is a small molecule inhibitor of cardiac-specific kinase TNNI3K (TNNI3 interacting kinase) [1]. It was derived from the scaffold of the multi-kinase inhibitor sorafenib (IC50 100nM vs. TNNI3K). GSK329 is suitable as an in vivo tool to assess inhibition of TNNI3K as a novel therapeutic strategy for the treatment of cardiovascular diseases.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 3
Rotatable bonds 8
Topological polar surface area 88.17
Molecular weight 471.05
XLogP 4.94
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CNc1ncnc(c1)Oc1c(Cl)cc(cc1Cl)NC(=O)Nc1cccc(c1)C(F)(F)F
Isomeric SMILES CNc1cc(Oc2c(Cl)cc(NC(=O)Nc3cccc(c3)C(F)(F)F)cc2Cl)ncn1
InChI InChI=1S/C19H14Cl2F3N5O2/c1-25-15-8-16(27-9-26-15)31-17-13(20)6-12(7-14(17)21)29-18(30)28-11-4-2-3-10(5-11)19(22,23)24/h2-9H,1H3,(H,25,26,27)(H2,28,29,30)
InChI Key QOQADIYOLOHRAW-UHFFFAOYSA-N
Bioactivity Comments
GSK329 was designed to be selective for TNNI3K compared to VEGFR2, p38α, and BRaf [1]. It is 40-fold more selective for human TNNI3K compared to VEGFR2, 80-fold selective against p38α, and and >200-fold selective against B-Raf.
Selectivity at enzymes
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
TNNI3 interacting kinase Hs Inhibitor Inhibition 9.3 pKi - 1
pKi 9.3 (Ki 5.4x10-10 M) [1]
TNNI3 interacting kinase Mm Inhibitor Inhibition 7.9 pKi - 1
pKi 7.9 (Ki 1.3x10-8 M) [1]
TNNI3 interacting kinase Hs Inhibitor Inhibition 8.0 pIC50 - 1
pIC50 8.0 (IC50 1x10-8 M) [1]
B-Raf proto-oncogene, serine/threonine kinase Hs Inhibitor Inhibition <5.7 pIC50 - 1
pIC50 <5.7 (IC50 >2x10-6 M) [1]